The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Metformin suppresses intestinal polyp growth in Apc Min/+ mice
Open accessAbstract
Metformin is a biguanide derivative that is widely used in the treatment of diabetes mellitus. One of the pharmacological targets of metformin is adenosine monophosphate-activated protein kinase (AMPK). We investigated the effect of metformin on the suppression of intestinal polyp formation in Apc(Min/+) mice. Administration of metformin (250 mg/kg) did not reduce the total number of intestinal polyp formations, but significantly reduced the number of intestinal polyp formations larger than 2 mm in diameter in Apc(Min/+) mice. To examine the indirect effect of metformin, the index of insulin resistance and serum lipid levels in Apc(Min/+) mice were assessed. These factors were not significantly attenuated by the treatment with metformin, indicating that the suppression of polyp growth is not due to the indirect drug action. The levels of tumor cell proliferation as determined by 5-bromodeoxyuridine and proliferating cell nuclear antigen immunohistochemical staining, and apoptosis, via transferase deoxytidyl uridine end labeling staining, in the polyps of metformin-treated mice were not significantly different in comparison to those of control mice. Gene expression of cyclin D1 and c-myc in intestinal polyps were also not significantly different between those two groups. In contrast, metformin activated AMPK in the intestinal polyps, resulting in the inhibition of the activation of mammalian target of rapamycin, which play important roles in the protein synthesis machinery. Metformin suppressed the polyp growth in Apc(Min/+) mice, suggesting that it may be a novel candidate as a chemopreventive agent for colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This epidemiologic evidence has coalesced with experimental work in animals(256–263).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [263]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 480
RetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591
Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,537
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature reviews. Cancer · doi:10.1038/35094017 · Cited by 1,077
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Cited by
Sorted by citations
Items 101–186 of 186
Metformin, Microbiome and Protection Against Colorectal Cancer
Jones, G. R. D., & Molloy, M. P. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06390-4 · Cited by 33
Cho, Y. H., Ko, B. M., Kim, S. H., Myung, Y. S., Choi, J. H., Han, J. P., Hong, S. J., Jeon, S. R., Kim, H. G., Kim, J. O., et al. (2014) · Intestinal Research · doi:10.5217/ir.2014.12.2.139 · Cited by 32
UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis
Li, T., Sun, X.-Z., & Jiang, X. (2017) · Tumor Biology · doi:10.1177/1010428317710823 · Cited by 32
Quattrini, I., Conti, A., Pazzaglia, L., Novello, C., Ferrari, S. M., Picci, P., & Benassi, M. S. (2013) · Oncology Reports · doi:10.3892/or.2013.2862 · Cited by 31
Kim, Y. H., Noh, R., Cho, S. Y., Park, S. J., Jeon, S. M., Shin, H. D., Kim, S. B., & Shin, J. E. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.2.145 · Cited by 31
Translating Mechanism-Based Strategies to Break the Obesity−Cancer Link: A Narrative Review
Smith, L. A., O’Flanagan, C. H., Bowers, L. W., Allott, E. H., & Hursting, S. D. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.08.112 · Cited by 33
Hou, Y.-C., Hu, Q., Huang, J., Fang, J.-Y., & Xiong, H. (2017) · Oncotarget · doi:10.18632/oncotarget.13633 · Cited by 29
New insight for metformin against bladder cancer
El‐Arabey, A. A. (2017) · Genes and Environment · doi:10.1186/s41021-017-0074-z · Cited by 28
Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
Anwar, S., Malik, J. A., Ahmed, S., Kameshwar, V. A., Alanazi, J., Alamri, A., & Ahemad, N. (2022) · Molecules · doi:10.3390/molecules27227668 · Cited by 30
Sehdev, A., & O’Neil, B. H. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0359-z · Cited by 28
Friend or Foe? Mitochondria as a Pharmacological Target in Cancer Treatment
Dickerson, T., Jauregui, C. E., & Teng, Y. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0110 · Cited by 28
Zell, J. A., McLaren, C. E., Morgan, T. R. M., Lawson, M. J., Rezk, S. A., Albers, G. C., Chen, W., Carmichael, J. C., Chung, J., Richmond, E. S., et al. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0262 · Cited by 29
Do metformin a real anticarcinogen? A critical reappraisal of experimental data.
Anisimov, V. N. (2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.06.02 · Cited by 28
Rabin-Court, A., Rodrigues, M. R. D. S., Zhang, X., & Perry, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218126 · Cited by 27
Mroueh, F. M., Noureldein, M. H., Zeidan, Y. H., Boutary, S. S., Irani, S. A. M., Eid, S., Haddad, M. E., Barakat, R., Harb, F., Costantine, J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900396rr · Cited by 26
Colon epithelial proliferation and carcinogenesis in diet‐induced obesity
Takahashi, H., Hosono, K., Endo, H., & Nakajima, A. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12240 · Cited by 26
Self-citationMetformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
Kang, H. E., Seo, Y., Yun, J. S., Song, S. H., Han, D., Cho, E. S., Cho, S. B., Jeon, Y., Lee, H., Kim, H. S., et al. (2021) · Cancers · doi:10.3390/cancers13143437 · Cited by 25
Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach
Zafari, N., Velayati, M., Damavandi, S., Pourali, G., Ghayour‐Mobarhan, M., Nassiri, M., Hassanian, S. M., Khazaei, M., Ferns, G. A., & Avan, A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220922111342 · Cited by 23
Effects of metformin on retinoblastoma growth in vitro and in vivo
Brodowska, K., Theodoropoulou, S., zu Hörste, M. M., Paschalis, E. I., Takeuchi, K., SCOTT, G., Ramsey, D. J., Kiernan, E. A., Hoang, M. V., Cichy, J., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2650 · Cited by 24
Targeting the Wnt Pathway in Cancer
Goss, K. H., & Kahn, M. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8023-6 · Cited by 23
Colorectal Cancer Chemoprevention: A Dream Coming True?
Signorile, M. L., Grossi, V., Fasano, C., & Simone, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087597 · Cited by 24
Management of colorectal cancer and diabetes
Yao, C., Nash, G. F., & Hickish, T. (2013) · Journal of the Royal Society of Medicine · doi:10.1177/0141076813512121 · Cited by 22
Kong, W., Chen, L., Zheng, J., Zhang, H., Hu, X., Zeng, T., & Hu, D. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214548998 · Cited by 23
Broadhurst, P. J., & Hart, A. R. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5233-y · Cited by 21
Metformin: risk-benefit profile with a focus on cancer
Provinciali, N., Lazzeroni, M., Cazzaniga, M., Gorlero, F., Dunn, B. K., & DeCensi, A. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1084289 · Cited by 21
Huang, Q., Yao, F., Zhou, C., Huang, X., Wang, Q., Long, H., & Wu, Q. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i24.6213 · Cited by 21
Metformin and Colorectal Cancer – A Systematic Review.
Kobiela, J., Dobrzycka, M., Jędrusik, P., Kobiela, P., Spychalski, P., Śledziński, Z., & Zdrojewski, T. R. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0621-8830 · Cited by 22
Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
Singhal, S., Maheshwari, P., Krishnamurthy, P. T., & Patil, V. M. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220317140557 · Cited by 18
Modification in Structures of Active Compounds in Anticancer Mitochondria-Targeted Therapy
Felczykowska, A., & Herman-Antosiewicz, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031376 · Cited by 21
The Effect of Metformin in Treatment of Adenomas in Patients with Familial Adenomatous Polyposis
Park, J. J., Kim, B. C., Hong, S. P., Seo, Y., Lee, H. S., Park, Y. S., Na, S., Park, S. C., Park, J., Kim, J. H., et al. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0580 · Cited by 18
Lee, D.-J., Kim, B., Lee, J. H., Park, S. J., Hong, S. P., Cheon, J. H., Kim, T. I., & Kim, W. H. (2012) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2012.60.6.355 · Cited by 17
Bak instead of Bax plays a key role in metformin-induced apoptosis s in HCT116 cells
Chen, H., Sun, B., Sun, H., Xu, L., Wu, G., Tu, Z., Cheng, X., Fan, X., Mai, Z., Tang, Q., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00755-y · Cited by 16
The influence of metformin in the etiology of selected cancers
Pawałowska, M., & Markowska, A. (2012) · Współczesna Onkologia · doi:10.5114/wo.2012.29289 · Cited by 16
Sravani, A. N. K. V., & Thomas, J. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41964 · Cited by 15
RetractedBrown, K. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.601 · Cited by 15
Peng, F., Hu, D., Lin, X., Liang, B., Chen, Y., Zhang, H., Xia, Y., Lin, J., Zheng, X., & Niu, W. (2018) · Aging · doi:10.18632/aging.101459 · Cited by 15
Metformin for cancer prevention
Yang, Y. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0112-3 · Cited by 14
Metformine et cancer : de nouvelles perspectives pour un ancien médicament
Loubière, C., Dirat, B., Tanti, J., & Bost, F. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.02.002 · Cited by 15
La obesidad como factor de riesgo en el desarrollo de cáncer
Herrera‐Covarrubias, D., Coria‐Ávila, G. A., Fernández–Pomares, C., Aranda-Abreu, G. E., Denes, J. M., & Hernández‐Aguilar, M. E. (2015) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2015.324.1771 · Cited by 14
Mansourian, M., Karimi, R., & Vaseghi, G. (2018) · EXCLI journal · doi:10.17179/excli2017-993 · Cited by 12
Higurashi, T., Arimoto, J., Ashikari, K., Takatsu, T., Misawa, N., Yoshihara, T., Matsuura, T., Fuyuki, A., Ohkubo, H., & Nakajima, A. (2020) · BMC Cancer · doi:10.1186/s12885-020-07564-z · Cited by 10
Self-citationZhang, R., Feng, C., Luo, D., Zhao, R., Kannan, P. R., Yin, Y., Iqbal, M. Z., Hu, Y., & Kong, X. (2023) · Pharmaceuticals · doi:10.3390/ph16091279 · Cited by 12
Ho, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2881 · Cited by 9
Animal Models of Colorectal Cancer in Chemoprevention and Therapeutics Development
Suman, S., Fornace, A. J., & Datt, K. (2012) · InTech eBooks · doi:10.5772/28497 · Cited by 9
The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes
Liao, K., Lai, S., & Li, C. (2012) · Libyan Journal of Medicine · doi:10.3402/ljm.v7i0.17532 · Cited by 9
Molecular and metabolic mechanisms underlying the obesity-cancer link
O’Flanagan, C. H., Bowers, L. W., Allott, E. H., & Hursting, S. D. (2018) · Research Portal (Queen's University Belfast) · Cited by 9
Lawler, T., Walts, Z. L., Giurini, L., Steinwandel, M. D., Lipworth, L. P., Murff, H. J., Zheng, W., & Andersen, S. W. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102566 · Cited by 9
AMPK Deficiency Increases DNA Methylation and Aggravates Colorectal Tumorigenesis in AOM/DSS Mice
Sun, Q., Tian, Q., Iniguez, A. B., Sun, X., Zhang, H., de Avila, J. M., Du, ., & Zhu, M. J. (2024) · Genes · doi:10.3390/genes15070835 · Cited by 8
Restricting Colorectal Cancer Cell Metabolism with Metformin: An Integrated Transcriptomics Study
Orang, A., Marri, S., McKinnon, R. A., Petersen, J., & Michael, M. (2024) · Cancers · doi:10.3390/cancers16112055 · Cited by 7
Fröhlich, E., & Wahl, R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01491.x · Cited by 6
Gonçalves, J., Pinto, S., Carmo, F., Silva, C., Andrade, N., & Martel, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105381 · Cited by 5
Thompson, M. D., Lubet, R. A., McCormick, D. L., Clapper, M. L., Bode, A. M., Juliana, M. M., Moeinpour, F. L., & Grubbs, C. J. (2017) · Oncology Letters · doi:10.3892/ol.2017.6632 · Cited by 5
Saif, M. W., Rajagopal, S., Caplain, J., Goodman, M. D., Popowich, D. A., Orkin, B. A., Tsichlis, P. N., & Martell, R. E. (2021) · PubMed · Cited by 5
Viollet, B., & Foretz, M. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70183-3 · Cited by 5
Metformin in Oncology – How Far Is Its Repurposing as an Anticancer Drug?
Pácal, L., & Kaňková, K. (2020) · Klinicka onkologie · doi:10.14735/amko2020107 · Cited by 6
Clinical efficacy of metformin in familial adenomatous polyposis and the effect of intestinal flora
Zhou, L., Zheng, L., Xu, B., Zhou, Y., Li, D., & Wang, W. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03064-6 · Cited by 4
Lee, J. H., & Kim, T. I. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-013-0198-x · Cited by 5
Immune Modulation by Agents Used in the Prevention and Treatment of Colon and Pancreatic Cancers
Janakiram, N. B., Mohammed, A., Lang, M. L., & Rao, C. V. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_13 · Cited by 4
Tomassini, L., Pacifico, T., Monteleone, G., Stolfi, C., & Laudisi, F. (2025) · Cells · doi:10.3390/cells14241968 · Cited by 3
Structural basis of polypharmacological effects of metformin
Han, W., & Xie, L. (2012) · IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) · doi:10.1109/bibmw.2012.6470337 · Cited by 3
Metformin, Microbiota and Health
Paz, G. S., & Fernandes, J. (2022) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2022.00032 · Cited by 3
Updates on Translational Research on Prevention of Polyps and Colorectal Cancer
Stoffel, E. M. (2018) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0037-1602235 · Cited by 4
Doses, mechanisms and the dandelion and hormetic phenomena
Martı́n-Castillo, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2010) · Cited by 3
Epithelial to Mesenchymal Transition (EMT)
Malviya, R., Singh, A. K., & Yadav, D. (2023) · doi:10.1002/9781394209866.ch7 · Cited by 3
Shadboorestan, A., Eftekhari, S., Mottaghi-Dastjerdi, N., Shahparvari, R., Tarighi, P., Jahandar, H., Faghihi, H., & Montazeri, H. (2022) · PubMed Central · doi:10.22038/ijbms.2022.64117.14117 · Cited by 3
The Biology of the Deadly Love Connection Between Obesity, Diabetes, and Breast Cancer
Bao, B., Oraha, A., Ahmad, A., Ali, S. S., Li, Y., Azmi, A. S., Banerjee, S., & Sarkar, F. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_7 · Cited by 2
Metformine et cancer : passé, présent, avenir
Loubière, C., Dirat, B., Tanti, J., & Bost, F. (2014) · Obésité · doi:10.1007/s11690-014-0418-9 · Cited by 3
Carson, J. A., & Puppa, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4493-0_5 · Cited by 2
Repurposing Metformin: Potential as a Prevention, Treatment and Adjunct Therapy in Pancreatic Cancer
Kamizela, E., Rudzińska, A., Ponikowski, K., Wrzosek, K., Gumółka, P., Oberda, J., Paluch, A., Haba, S., Jakubik, K., Kolasa, E., et al. (2024) · Quality in Sport · doi:10.12775/qs.2024.36.56451 · Cited by 1
Shen, M., Lü, S., Xu, Z., Zhou, F., Sheng, L., & Yu, Q. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1645387 · Cited by 1
Mouse Models to Study Metformin Effects in Carcinogenesis
Schneider, A. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_13 · Cited by 1
N -methylnitrosourea aggravates gastrointestinal polyposis in Lkb1+/− mice
Udd, L., Gao, Y., Ristimaki, A. P., & Mäkelä, T. P. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt188 · Cited by 1
Aoki, M., & Taketo, M. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-8023-6_7 · Cited by 1
Is Metformin a Treatment Opportunity for Colorectal Cancer?
Eroglu, E., & Uzun, Ö. (2020) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2020/172 · Cited by 1
Response to Letter to the Editor: Metformin in colorectal cancer: A match ruled by MiR26b?
Linkevičiūtė-Ulinskienė, D., Dulskas, A., Patašius, A., Zabulienė, L., Urbonas, V., & Smailytė, G. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101626 · Cited by 1
Checkley, L. A. (2012) · Digital Commons-TMC (Texas Medical Center)
Antidiabeticheskiy biguanid metforminkak geroprotektor i antikantserogen
Anisimov, V. N. (2011) · Obesity and metabolism · doi:10.14341/2071-8713-4832
Martı́n-Castillo, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)62003-0
Metabolic Perturbations Associated with Adipose Tissue Dysfunction and the Obesity–Cancer Link
Ford, N. A., DiGiovanni, J., & Hursting, S. D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7660-3_1
AMP-Activated Protein Kinase and Cancer Cell Metabolism
Zheng, B., & Cantley, L. C. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_9
Metformin and Cancer: past, present, future
Loubière, C., Dirat, B., & Bost, F. (2014)
Gastrointestinal Cancer Prevention: Diet, Lifestyle, and Therapeutic Prevention
Tran, P. N., & Zell, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-18890-0_29
Liao, L., Wang, G., Li, Y., Zou, D., Liu, J., Ma, B., Ma, J. H., Li, Y., Qi, Y., Ma, J. H., et al. (2026) · Case Reports in Medicine · doi:10.1155/carm/6766219
Xue, K.-L., Xiao-hua, J., Qi, W.-T., Wang, J.-W., & Liang, L. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.118213
Metadata
- Authors
- Tomimoto, A., Endo, H., Sugiyama, M., Fujisawa, T., Hosono, K., Takahashi, H., Nakajima, N., Nagashima, Y., Wada, K., Nakagama, H., & Nakajima, A.
- Affiliations
- National Institute of Infectious Diseases (JP)
- Yokohama City University (JP)
- The University of Osaka (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Nakajima, Atsushi
- ORCID
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2008-11
- Volume
- 99
- Issue
- 11
- Pages
- 2136-2141
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- PMC
- PMC11159964
- OpenAlex
- W2140983197
- Cited by
- 185
- References
- 24
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 9 · 2021: 7 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 9 · 2016: 6 · 2015: 15 · 2014: 20 · 2013: 16 · 2012: 22
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Science (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Biomedical Innovation
- Princess Takamatsu Cancer Research Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- metformin, intestinal polyps, ApcMin/+ mice, AMPK, mTOR, colorectal cancer chemoprevention, insulin resistance, serum lipids, tumor cell proliferation, apoptosis, cyclin D1, c-Myc
- MeSH terms
- Animals, Immunohistochemistry, Intestinal Polyps, Metformin, Mice, Inbred C57BL, Mice, Transgenic, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myc, Anticarcinogenic Agents, Genes, APC, Cyclin D1, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
